- Maruti Suzuki’s net income for the third quarter increased by 13% year-over-year to 35.3 billion rupees, but it fell short of the estimate of 36.04 billion rupees.
- The company’s revenue reached 384.9 billion rupees, marking a 16% rise year-over-year, slightly above the expected 384.36 billion rupees.
- Total costs for Maruti Suzuki were 348.8 billion rupees, which is a 16% increase year-over-year.
- Raw material costs climbed by 17% year-over-year, reaching 129.9 billion rupees.
- Employee benefits expenses rose by 15% year-over-year to 15.4 billion rupees, surpassing the estimate of 14.61 billion rupees.
- Market analysts’ recommendations include 36 “buys”, 9 “holds”, and 3 “sells”.
A look at Maruti Suzuki India Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Maruti Suzuki India, a key player in the automobile industry, shows promising signs for its long-term outlook based on the Smartkarma Smart Scores. With robust scores in Dividend, Growth, Resilience, and Momentum (all at levels of 4), it indicates strong performance across key factors. This suggests a positive trend for the company’s future profitability and stability.
As Maruti Suzuki India Limited focuses on manufacturing and exporting automobiles, its collaboration with Suzuki of Japan has enabled them to cater to the demand for affordable cars in the Indian market. With solid scores in Value, Dividend, Growth, Resilience, and Momentum, Maruti Suzuki India appears well-positioned for sustained success in the competitive automotive sector.
Summary: Maruti Suzuki India Limited manufactures and exports automobiles. Maruti collaborated with Suzuki of Japan to produce affordable cars for the average Indian.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
